The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer

NCT05735028 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Centipeda minima+PD-1/PD-L1 inhibitor
DRUG: PD-1/PD-L1 inhibitor

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University